Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Matthias Will"'
Autor:
Gilles Salles, Stephen J. Schuster, Sven de Vos, Nina D. Wagner-Johnston, Andreas Viardot, Kristie A. Blum, Christopher R. Flowers, Wojciech J. Jurczak, Ian W. Flinn, Brad S. Kahl, Peter Martin, Yeonhee Kim, Sanatan Shreay, Matthias Will, Bess Sorensen, Madlaina Breuleux, Pier Luigi Zinzani, Ajay K. Gopal
Publikováno v:
Haematologica, Vol 102, Iss 4 (2017)
Externí odkaz:
https://doaj.org/article/659c521f054746b8aea3c4d816e10163
Autor:
Mario L Marques‐Piubelli, Jason Sagert, Minh Thu Pham, Matthias Will, Dan Henderson, Kimberly Tipton, Swaminathan Iyer, Wei Lu, Khaja B Khan, Leticia Hamana, Jennifer R Chapman, Beenu Thakral, Jie Xu, Roberto N Miranda, Kristofer Jennings, Luisa M Solis, Francisco Vega
Publikováno v:
Histopathology. 81:272-275
Autor:
Simon Paulus, Michael Roser, Patrick McKearney, Matthias Will, Sören Schäfer, Stefan Kontermann
Crystalline silicon becomes photosensitive and absorbing in the sub-bandgap spectral region if hyperdoped, i.e. supersaturated to a level above the solubility limit in thermal equilibrium, by deep impurities, such as sulfur. Here we apply femtosecond
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31510162d30f73f31c90fbe7b8867ef3
https://opus4.kobv.de/opus4-h-da/frontdoor/index/index/docId/393
https://opus4.kobv.de/opus4-h-da/frontdoor/index/index/docId/393
Autor:
Kelly Shi, Cindy Tan, Lu Bai, Jennifer Richardson, Andy Deng, Matthias Will, Michael Brehm, Dale Greiner, Leonard Shultz, Antonella Teramo, Renato Zambello, David J Feith, Thomas P. Loughran, Nenad Tomasevic
Publikováno v:
Blood. 140:2259-2260
Autor:
Erika Hamilton, C. Murias, Daniel C. Cho, Patricia LoRusso, Kevin Kalinsky, Patrick A. Ott, Matthias Will, V Huels, B Benson, Sylvia Adams, H.-T. Arkenau
Publikováno v:
Cancer Research. 79:P6-18
Background: Probody™ therapeutics are novel, fully recombinant antibody prodrugs designed to remain relatively inactive in healthy tissue and to be specifically activated by proteases in the tumor microenvironment. In this way, Probody therapeutics
Autor:
Georg Rose, Matthias Will, Christoph Reichert, Tobias Peter, Norbert Elkmann, Hermann Hinrichs, Magnus Hanses
Publikováno v:
SMC
Brain-machine interfaces (BMI) open new opportunities to control robotic devices as they provide the feasibility to translate brain signals into commands. Severely motor impaired people who have lost muscle control could benefit from this technique t
Autor:
Mary-Lee Dequeant, Pooja Keerthipati, Tony W. Ho, Jonathan Alexander Terrett, Minh Thu Pham, Julie Carson, Ewelina Morawa, Zinkal Padalia, Matthias Will, Sushant Karnik
Publikováno v:
Cancer Research. 80:6595-6595
T cell lymphomas account for 10% to 15% of non-Hodgkin lymphomas and are diverse biologically and clinically. Unlike B-cell lymphomas, T cell lymphomas are rather resistant to conventional therapies, such as chemotherapy and antibody-based therapeuti
Autor:
Mary J. Fidler, Ruth Plummer, Karen A. Autio, E. G. E. de Vries, Rachel E. Sanborn, H.-T. Arkenau, C. W. Menke-van der Houven van Oordt, Anthony B. El-Khoueiry, Valentina Boni, Jerzy Wydmański, Patricia LoRusso, R. Humphrey, J. Garcia-Corbacho, Nataliya Volodymyrivna Uboha, Fiona C Thistlethwaite, Matthias Will
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology, 29. Oxford University Press
Plummer, R, Sanborn, R E, de Vries, E G E, Lorusso, P, Arkenau, H T, Uboha, N, Wydmanski, J, Fidler, M J, Boni, V, Garcia-Corbacho, J, Humphrey, R, Will, M, Autio, K A, El-Khoueiry, A B, Menke-van der Houven van Oordt, C W & Thistlethwaite, F 2018, ' Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii143 . https://doi.org/10.1093/annonc/mdy279.423
Plummer, R, Sanborn, R E, de Vries, E G E, Lorusso, P, Arkenau, H T, Uboha, N, Wydmanski, J, Fidler, M J, Boni, V, Garcia-Corbacho, J, Humphrey, R, Will, M, Autio, K A, El-Khoueiry, A B, Menke-van der Houven van Oordt, C W & Thistlethwaite, F 2018, ' Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii143 . https://doi.org/10.1093/annonc/mdy279.423
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e57618c225a868258754e76a06d5fc7e
https://research.vumc.nl/en/publications/bd35436b-dc2d-497d-8923-ce145e583864
https://research.vumc.nl/en/publications/bd35436b-dc2d-497d-8923-ce145e583864
Autor:
Matthias Will
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
Photonics, Devices, and Systems VII.
Interference of light provides a high precision, non-contact and fast method for measurement method for distances. Therefore this technology dominates in high precision systems. However, in the field of compact sensors capacitive, resistive or induct